PMAQX
Price
$47.81
Change
-$0.16 (-0.33%)
Updated
Sep 16 closing price
Net Assets
33.2B
WMGAX
Price
$26.64
Change
-$0.19 (-0.71%)
Updated
Sep 16 closing price
Net Assets
4.63B
Interact to see
Advertisement

PMAQX vs WMGAX

Header iconPMAQX vs WMGAX Comparison
Open Charts PMAQX vs WMGAXBanner chart's image
Principal MidCap R6
Price$47.81
Change-$0.16 (-0.33%)
VolumeN/A
Net Assets33.2B
Macquarie Mid Cap Growth A
Price$26.64
Change-$0.19 (-0.71%)
VolumeN/A
Net Assets4.63B
PMAQX vs WMGAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
PMAQX vs. WMGAX commentary
Sep 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PMAQX is a Buy and WMGAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PMAQX has more cash in the bank: 33.2B vs. WMGAX (4.63B). PMAQX pays higher dividends than WMGAX: PMAQX (0.18) vs WMGAX (0.00). PMAQX was incepted earlier than WMGAX: PMAQX (9 years) vs WMGAX (25 years). WMGAX (1.23) is less costly to investors than PMAQX (0.59). WMGAX is a more actively managed with annual turnover of: 42.00 vs. PMAQX (10.50). PMAQX has a lower initial minimum investment than WMGAX: PMAQX (0) vs WMGAX (1000). PMAQX annual gain was more profitable for investors over the last year : 6.77 vs. WMGAX (-1.14). PMAQX return over 5 years is better than : 50.09 vs. WMGAX (-18.33).
PMAQXWMGAXPMAQX / WMGAX
Total Expense Ratio0.591.0457%
Annual Report Gross Expense Ratio0.591.2348%
Fund Existence9 years25 years-
Gain YTD7.4846.807110%
Front LoadN/A6%-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets33.2B4.63B718%
Annual Yield % from dividends0.180.00-
Returns for 1 year6.77-1.14-592%
Returns for 3 years49.861.094,563%
Returns for 5 years50.09-18.33-273%
Returns for 10 yearsN/A25.02-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GERAX10.87N/A
N/A
Goldman Sachs Em Mkts Eq Insghts A
SUHAX36.19N/A
N/A
DWS Health and Wellness A
TRGMX22.45N/A
N/A
Nuveen Quant Mid Cap Growth Retire
BGGSX31.58N/A
N/A
Baillie Gifford US Equity Growth I
VHIAX43.38N/A
N/A
JPMorgan Growth Advantage A